The Consumer Financial Protection Bureau is reconsidering a set of recent consumer protections that won broad public support, signaling a major shift at the watchdog agency. New leaders are reviewing policies on medical debt and overdraft fees, according to people following the changes. The moves could affect household finances across the country and reset a decade of consumer policy.
From medical debt to overdraft fees, the Consumer Financial Protection Bureau’s new leaders are targeting recent policies that advocates hoped would be too popular to touch.
The reviews come amid a change in leadership and priorities at the bureau. Consumer groups warn that rollbacks could raise costs for families. Banks and lenders argue that tough rules reduced credit access and limited choices.
Background: How We Got Here
In recent years, the bureau focused on what it called “junk fees,” with special attention to overdraft and non-sufficient funds charges. Several large banks cut or eliminated such fees after regulatory pressure and public criticism. Industry fee revenue fell, though estimates vary by source.
The bureau also moved to limit the role of medical debt in credit reporting. Major credit bureaus already removed many small medical debts and excluded paid items. The agency proposed a nationwide rule to keep medical bills off credit reports, arguing that illness is not a reliable measure of credit risk.
Supporters said these steps helped millions with unexpected bills or tight cash flow. Hospitals, debt collectors, and some lenders pushed back, saying the rules had unintended effects and could increase costs elsewhere.
Medical Debt Rules Under Review
The new leadership is reassessing whether to bar medical debt from credit reports. Consumer advocates say the change would put negative marks back on files and hurt people after a health crisis. They note that medical billing errors are common and that many borrowers do not choose when they get care.
Hospital groups and some lenders counter that removing medical debt distorts risk data. They argue that credit files should reflect outstanding obligations so that lenders can price loans accurately. They also point to charity care programs and payment plans as alternatives to blanket bans.
Several states have set their own guardrails on medical collections. Any federal shift could either override or collide with those rules, setting up legal questions and compliance costs for providers and bureaus.
Overdraft Fees Back in the Spotlight
The bureau previously advanced plans to treat large, recurring overdraft fees as credit, which could trigger disclosures and rate limits. Banks warned that strict caps would end low-cost checking for some customers and reduce free services. Consumer groups said high fees punished people living paycheck to paycheck and were out of line with the cost of covering a shortfall.
Some large banks had already cut overdraft fees or added grace periods. With the review underway, industry executives are pressing for broader flexibility. They want safe harbors for small overdrafts, more room for monthly fee models, and clear rules for real-time payments, where timing matters.
What Stakeholders Are Saying
- Consumer advocates: Reversals could raise costs for families, worsen credit scores, and discourage people from seeking care.
- Banks and credit unions: Overly strict rules reduce product choice, limit small-dollar liquidity, and may push users to higher-cost credit.
- Credit bureaus and collectors: Consistent national standards are needed to avoid a patchwork of state rules.
Academic researchers note that overdraft revenue fell as banks changed policies over the last few years. They also point out that alternative fees often replaced overdrafts, such as monthly maintenance charges, which can hit different customers.
Legal and Market Paths Ahead
Any major policy change will likely face court challenges. The bureau must show that new rules are grounded in law and supported by data. If leadership pulls back from rulemaking, it could use guidance and enforcement choices to shape behavior instead.
Markets may move before the ink dries. Banks could reprice accounts or test subscription-style checking. Credit bureaus might adjust reporting practices while awaiting final decisions, given operational lead times.
The coming months will show whether the agency narrows, rewrites, or withdraws rules on medical debt and overdraft fees. For households, the stakes are clear: how health bills appear on credit files and what it costs to cover a short-term shortfall. For lenders, the outcome will shape product design and fee models. Watch for draft rules, comment periods, and early legal filings that signal the final direction.
